UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

The Prevalence of Plaque Psoriasis, Psoriatic Arthritis And The Overlap Between Them In Norway

Value in health, 2016, Vol.19 (7), p.A578-A578

2016

Volltextzugriff (PDF)

Estimating the Value of A New Antibiotic: A Novel Approach Using Esbl As A Case Study

Value in health, 2016, Vol.19 (7), p.A422-A423

2016

Volltextzugriff (PDF)

The Association Between Disease Activity and Health-Related Quality of Life in RRMS Patients

VALUE IN HEALTH, 2017-10, Vol.20 (9), p.A728

2017

Volltextzugriff (PDF)

Review of Health Economic Models for Antibiotics

Value in health, 2016, Vol.19 (7), p.A373-A373

2016

Volltextzugriff (PDF)

Squaring the Circle? Using Real World Data from Early Access Programs to Inform Pricing and Reimbursement Decision Making

Value in health, 2018-05, Vol.21, p.S52

2018

Volltextzugriff (PDF)

PCP15 - Squaring the Circle? Using Real World Data from Early Access Programs to Inform Pricing and Reimbursement Decision Making

Value in health, 2018-05, Vol.21, p.S52-S52

2018

Volltextzugriff (PDF)

Nice and single? Recommendation Rates Of Oncology Therapies Approved On Clinical Trial Packages Lacking Comparative Phase 3 Data

Value in health, 2017-10, Vol.20 (9), p.A457

2017

Volltextzugriff (PDF)

PCN251 - Nice and single? Recommendation Rates Of Oncology Therapies Approved On Clinical Trial Packages Lacking Comparative Phase 3 Data

Value in health, 2017-10, Vol.20 (9), p.A457-A457

2017

Volltextzugriff (PDF)

EE272 Cost-Effectiveness of Voclosporin in Combination with Mycophenolate Mofetil for Active Lupus Nephritis in Sweden

Value in health, 2023-12, Vol.26 (12), p.S103-S104

2023

Volltextzugriff (PDF)

Patients With High-disease-activity Relapsing-Remitting Multiple Sclerosis in Real-world Clinical Practice: A Population-based Study in Sweden

Clinical therapeutics, 2020-02, Vol.42 (2), p.240-250

2020

Volltextzugriff (PDF)

Abstract P1-16-10: Treatment patterns and outcomes of different subtypes of metastatic breast cancer patients in a Swedish real world setting with a focus on HER2-/HR+ subtype

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-16-10

2019

Volltextzugriff (PDF)

Advanced Parkinson’s Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs?

Value in health, 2016-11, Vol.19 (7), p.A351-A352

2016

Volltextzugriff (PDF)

ND2 - Advanced Parkinson’s Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs?

Value in health, 2016-11, Vol.19 (7), p.A351-A352

2016

Volltextzugriff (PDF)

Navigating Real World Evidence in Oncology – Where to Go and Why

Value in health, 2018-05, Vol.21, p.S218

2018

Volltextzugriff (PDF)

Mission Possible? Demonstrating Robust Cost-Effectiveness without Any Comparative Phase 3 Data

Value in health, 2018-05, Vol.21, p.S120

2018

Volltextzugriff (PDF)

PRM47 - Navigating Real World Evidence in Oncology – Where to Go and Why

Value in health, 2018-05, Vol.21, p.S218-S218

2018

Volltextzugriff (PDF)

PHP220 - Mission Possible? Demonstrating Robust Cost-Effectiveness without Any Comparative Phase 3 Data

Value in health, 2018-05, Vol.21, p.S120-S120

2018

Volltextzugriff (PDF)

PRM91 - Review of Health Economic Models for Antibiotics

Value in health, 2016-11, Vol.19 (7), p.A373-A373

2016

Volltextzugriff (PDF)

PIN89 - Estimating the Value of A New Antibiotic: A Novel Approach Using Esbl As A Case Study

Value in health, 2016-11, Vol.19 (7), p.A422-A423

2016

Volltextzugriff (PDF)

PSY23 - The Prevalence of Plaque Psoriasis, Psoriatic Arthritis And The Overlap Between Them In Norway

Value in health, 2016-11, Vol.19 (7), p.A578-A578

2016

Volltextzugriff (PDF)

PND61 - The Association Between Disease Activity and Health-Related Quality of Life in RRMS Patients

Value in health, 2017-10, Vol.20 (9), p.A728-A728

2017

Volltextzugriff (PDF)

PSS48 - Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients: A Real-World Study In Sweden

Value in health, 2017-10, Vol.20 (9), p.A809-A809

2017

Volltextzugriff (PDF)

Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients: A Real-World Study In Sweden

Value in health, 2017-10, Vol.20 (9), p.A809

2017

Volltextzugriff (PDF)

PRS46 - Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden

Value in health, 2016-11, Vol.19 (7), p.A556-A556

2016

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden

Value in health, 2016-11, Vol.19 (7), p.A556-A556

2016

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Prevalence of Plaque Psoriasis, Psoriatic Arthritis And The Overlap Between Them In Norway

Estimating the Value of A New Antibiotic: A Novel Approach Using Esbl As A Case Study

The Association Between Disease Activity and Health-Related Quality of Life in RRMS Patients

Review of Health Economic Models for Antibiotics

Squaring the Circle? Using Real World Data from Early Access Programs to Inform Pricing and Reimbursement Decision Making

PCP15 - Squaring the Circle? Using Real World Data from Early Access Programs to Inform Pricing and Reimbursement Decision Making

Nice and single? Recommendation Rates Of Oncology Therapies Approved On Clinical Trial Packages Lacking Comparative Phase 3 Data

PCN251 - Nice and single? Recommendation Rates Of Oncology Therapies Approved On Clinical Trial Packages Lacking Comparative Phase 3 Data

EE272 Cost-Effectiveness of Voclosporin in Combination with Mycophenolate Mofetil for Active Lupus Nephritis in Sweden

Patients With High-disease-activity Relapsing-Remitting Multiple Sclerosis in Real-world Clinical Practice: A Population-based Study in Sweden

Abstract P1-16-10: Treatment patterns and outcomes of different subtypes of metastatic breast cancer patients in a Swedish real world setting with a focus on HER2-/HR+ subtype

Advanced Parkinson’s Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs?

ND2 - Advanced Parkinson’s Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs?

Navigating Real World Evidence in Oncology – Where to Go and Why

Mission Possible? Demonstrating Robust Cost-Effectiveness without Any Comparative Phase 3 Data

PRM47 - Navigating Real World Evidence in Oncology – Where to Go and Why

PHP220 - Mission Possible? Demonstrating Robust Cost-Effectiveness without Any Comparative Phase 3 Data

PRM91 - Review of Health Economic Models for Antibiotics

PIN89 - Estimating the Value of A New Antibiotic: A Novel Approach Using Esbl As A Case Study

PSY23 - The Prevalence of Plaque Psoriasis, Psoriatic Arthritis And The Overlap Between Them In Norway

PND61 - The Association Between Disease Activity and Health-Related Quality of Life in RRMS Patients

PSS48 - Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients: A Real-World Study In Sweden

Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients: A Real-World Study In Sweden

PRS46 - Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden

Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden

Suchergebnisse filtern